Dagli-Hernandez, C.; Borges, J.B.; Marçal, E.d.S.R.; de Freitas, R.C.C.; Mori, A.A.; Gonçalves, R.M.; Faludi, A.A.; de Oliveira, V.F.; Ferreira, G.M.; Bastos, G.M.;
et al. Genetic Variant ABCC1 rs45511401 Is Associated with Increased Response to Statins in Patients with Familial Hypercholesterolemia. Pharmaceutics 2022, 14, 944.
https://doi.org/10.3390/pharmaceutics14050944
AMA Style
Dagli-Hernandez C, Borges JB, Marçal EdSR, de Freitas RCC, Mori AA, Gonçalves RM, Faludi AA, de Oliveira VF, Ferreira GM, Bastos GM,
et al. Genetic Variant ABCC1 rs45511401 Is Associated with Increased Response to Statins in Patients with Familial Hypercholesterolemia. Pharmaceutics. 2022; 14(5):944.
https://doi.org/10.3390/pharmaceutics14050944
Chicago/Turabian Style
Dagli-Hernandez, Carolina, Jéssica Bassani Borges, Elisangela da Silva Rodrigues Marçal, Renata Caroline Costa de Freitas, Augusto Akira Mori, Rodrigo Marques Gonçalves, Andre Arpad Faludi, Victor Fernandes de Oliveira, Glaucio Monteiro Ferreira, Gisele Medeiros Bastos,
and et al. 2022. "Genetic Variant ABCC1 rs45511401 Is Associated with Increased Response to Statins in Patients with Familial Hypercholesterolemia" Pharmaceutics 14, no. 5: 944.
https://doi.org/10.3390/pharmaceutics14050944
APA Style
Dagli-Hernandez, C., Borges, J. B., Marçal, E. d. S. R., de Freitas, R. C. C., Mori, A. A., Gonçalves, R. M., Faludi, A. A., de Oliveira, V. F., Ferreira, G. M., Bastos, G. M., Zhou, Y., Lauschke, V. M., Cerda, A., Hirata, M. H., & Hirata, R. D. C.
(2022). Genetic Variant ABCC1 rs45511401 Is Associated with Increased Response to Statins in Patients with Familial Hypercholesterolemia. Pharmaceutics, 14(5), 944.
https://doi.org/10.3390/pharmaceutics14050944